Atlas Trials

Supplementation of L-arginine in Patients With Non-resectable Brain Metastases

Clinical trial NCT02844387 · COMPLETED

Trial details

NCT number
NCT02844387
Sponsor
Instituto de Oncología Ángel H. Roffo
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Unresectable Multiple Brain Metastases
Start date
2004-05-01
Primary completion
2007-11-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.